Evidence map›Paper›PMID 26319012›Full record

ReviewGastroenterology2015

Zebrafish: an important tool for liver disease research.

Wolfram Goessling, Kirsten C Sadler

Open access · greenAbstract readReview
In one paragraph

Review in Gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 310 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Tetrandrine, a Major Alkaloid FromFood science & nutrition · 2026
    Article
  7. Article
  8. A Novel Zebrafish Liver-Specific Metastasis Model Reveals c-Met as a Driver of Liver Tropism.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Chios Mastic Gum Extract Enhances Antioxidant Defense in Zebrafish.International journal of molecular sciences · 2025
    Article
  17. Article
  18. Article
  19. Long Term Culture of Germ-Free Zebrafish Using Gamma-Irradiated Feeds.bioRxiv : the preprint server for biology · 2025
    Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Wolfram GoesslingDivisions of Genetics and Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts; Broad Institute of MIT and Harvard, Harvard Medical School, Boston, Massachusetts.
Kirsten C SadlerDepartment of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: kirsten.edepli@nyu.edu.
Brigham and Women's Hospital · USIcahn School of Medicine at Mount Sinai · US

Funding

Role of Uhrf1 in Liver Development, Regeneration and CarciogenesisR01DK080789 · NIDDK · NEW YORK UNIVERSITY · PI Kirsten C Sadler Edepli · 2009 to 2026
$5.2M
Estrogen Regulation of Hepatic GrowthR01DK090311 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2011 to 2020
$4.9M
Understanding fatty liver disease using the zebrafish mutant, foie grasR01AA018886 · NIAAA · NEW YORK UNIVERSITY · PI SADLER EDEPLI, KIRSTEN C · 2009 to 2017
$2.4M
NIAAA NIH HHS 5R01AA018886NIAAA NIH HHS R01 AA018886NIDDK NIH HHS 5R01DK080789NIDDK NIH HHS R01 DK080789NIDDK NIH HHS R01 DK090311NIDDK NIH HHS R01DK090311
6 · The paper itself

Abstract

As the incidence of hepatobiliary diseases increases, we must improve our understanding of the molecular, cellular, and physiological factors that contribute to the pathogenesis of liver disease. Animal models help us identify disease mechanisms that might be targeted therapeutically. Zebrafish (Danio rerio) have traditionally been used to study embryonic development but are also important to the study of liver disease. Zebrafish embryos develop rapidly; all of their digestive organs are mature in larvae by 5 days of age. At this stage, they can develop hepatobiliary diseases caused by developmental defects or toxin- or ethanol-induced injury and manifest premalignant changes within weeks. Zebrafish are similar to humans in hepatic cellular composition, function, signaling, and response to injury as well as the cellular processes that mediate liver diseases. Genes are highly conserved between humans and zebrafish, making them a useful system to study the basic mechanisms of liver disease. We can perform genetic screens to identify novel genes involved in specific disease processes and chemical screens to identify pathways and compounds that act on specific processes. We review how studies of zebrafish have advanced our understanding of inherited and acquired liver diseases as well as liver cancer and regeneration.

Indexed as

Disease Models, AnimalLiverLiver DiseasesZebrafishAnimalsHumansDevelopmentLiver CancerRegenerationTechnologyToxicology

Identifiers

PMID26319012
PMCPMC4762709
OpenAlexW1121521847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.